Poland has continued to grow by attracting investment on the back of relatively low-cost labor, but it now identifies moving domestic industries up the value chain through innovation as a growth driver. An interview with a former presidential office official sheds light on the country’s economic transformation and the direction of its pharmaceutical industry.
For many years, Poland grew by attracting foreign investment on the strength of its relatively low-cost labor. As the wage gap with other European countries narrows, the country is seeking to move domestic industries up the value chain, with innovation as a new growth engine.
Piotr Cwik spoke to this publication about changes in the Polish economy, its challenges ahead and the direction of the pharmaceutical industry. Drawing on his experience as Secretary of State and Undersecretary of State in the Office of the President, he explained the links between policy and industry.
Alongside progress in upgrading industries through innovation, the focus will be on how the Polish government advances the development of strategic sectors, including pharmaceuticals. The challenges ahead include sustaining technological innovation and strengthening international competitiveness.
The interview offers indications of the direction in which Poland’s economic transformation may proceed. Attention is focused on the policies and investment needed to determine the international competitiveness of domestic industries.